Hydroxyurea | Radio Compass News

SIKLOS® (hydroxyurea) is now covered by State Medicaid programs in 19 states

21 Sep 2023 //

GLOBENEWSWIRE

EMA Approves OXBRYTA in EU to Target the Cause of SCD

25 Feb 2022 //

PRNEWSWIRE

EAMS Scientific Opinion Awarded to Voxelotor for Haemolytic Anaemia Due to SCD

27 Jan 2022 //

GLOBENEWSWIRE

Positive CHMP opinion for sickle cell disease anaemia tablet

20 Dec 2021 //

PHARMAFILE

NICE turns down Novartis` Adakveo

27 Nov 2020 //

PHARMATIMES

Novartis sickle cell medicine Adakveo® approved in Europe to prevent recurrent

30 Oct 2020 //

NOVARTIS

Siklos®, the first and only hydroxyurea-based treatment for pediatric patients

19 Oct 2020 //

PRNEWSWIRE

Leading Pharma`s Generic Hydroxyurea Receives Approval In US

11 Apr 2020 //

FDA

‘Revolutionary’ liquid sickle cell treatment unveiled

25 Oct 2019 //

PHARMATIMES

Siklos` hydroxyurea-based Tx for Pediatric Pts now available

20 Aug 2018 //

PR NEWSWIRE

Novartis Announces Positive Data on Sickle Cell Disease Drug

12 Dec 2017 //

NASDAQ

Novartis announces phII Sustain study of SEG101

05 Dec 2016 //

PHARMABIZ

Phase III Study Shows Jakavi is Superior to Standard Therapy in Rare Blood Cancer Polycythemia Vera

29 Jan 2015 //